| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 10,124,986 | 7,171,098 | 4,867,978 | | Cost of Revenue | 2,371,906 | 1,315,114 | 890,732 | | | Gross Profit | 7,753,080 | 5,855,984 | 3,977,246 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,838,508 | 2,206,322 | 1,503,615 | | Non Recurring | 442,747 |
-
|
-
| | Others | 1,935,875 | 1,443,472 | 1,076,312 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,535,950 | 2,206,190 | 1,397,319 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,088,062) | 109,005 | 1,223 | | Earnings Before Interest And Taxes | 1,386,868 | 2,315,195 | 1,398,542 | | Interest Expense | 495,634 | 194,839 | 186,404 | | Income Before Tax | 891,234 | 2,120,356 | 1,212,138 | | Income Tax Expense | 303,934 | 593,928 | 390,663 | | Minority Interest | (62,966) | (63,722) | (8,104) | | | | Net Income From Continuing Ops | 524,334 | 1,462,706 | 813,371 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (1,882) | | Other Items |
-
|
-
|
-
| | | | Net Income | 524,334 | 1,462,706 | 811,489 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $524,334 | $1,462,706 | $811,489 |
|
1.48% Nasdaq 0.00%
Income Statement
